Lutein Supplementation May Improve Outcomes in Early AMD - Takeaways - MDSpire
From the Journals

Lutein Supplementation May Improve Outcomes in Early AMD

Meta-analysis found statistically significant improvements, with clearest benefits in early-stage disease

  • By

  • Andrea Surnit

  • May 5, 2026

  • 3 min

Share

  • 1

    Lutein supplementation improves MPOD and BCVA in early AMD.

  • 2

    Study included 9 randomized trials with 860 patients.

  • 3

    Doses ranged from 2 mg/day to 20 mg/day.

  • 4

    Significant benefits were not observed in late-stage AMD.

  • 5

    Longer supplementation duration correlates with better outcomes.

  • 6

    Further research needed on long-term effects.

  • 7

    The AREDS2 formulation serves as a clinical reference.

  • 8

    No conflicts of interest or external funding reported.

Original Source(s)

Lutein Supplementation May Improve Outcomes in Early AMD

  • by Andrea Surnit

  • May 5, 2026

Related Content

Early Experience of Superior Efficiency with UNITY® VCS/CS

Four leading surgeons discuss their early experience with Alcon’s UNITY® VCS/CS platform

  • May 5, 2026

  • 9 min
Is Europe Safe from the Myopia Epidemic?

As global myopia rates soar, three landmark meta-analyses examine the European epidemiological landscape

AI Boosts Diabetic Eye Care Access

Recent study highlights how integrated AI-assisted DR screening in primary care clinics can improve access and decrease disparity

  • May 5, 2026

  • 3 min